Munich Reinsurance Co Stock Corp in Munich Boosts Position in HCA Healthcare, Inc. $HCA

Key Points

• Munich Re boosted its stake in HCA by 335.4% in Q4 to 24,245 shares, worth about $11.47 million, and institutional investors now own roughly 62.73% of the company.
• HCA reported Q1 EPS of $7.15 (vs. $7.19 expected) and revenue of $19.11 billion (+4.3%), but the stock fell ~8.6% after weakness in surgical volumes and FY2026 guidance of $29.10–$31.50 EPS that sits slightly below street expectations.
• The company declared a quarterly dividend of $0.78 (annualized $3.12, ~0.7% yield), while insiders sold about 15,214 shares (~$7.8M) in the past 90 days and now own 1.5% of the stock.

Munich Reinsurance Co Stock Corp in Munich raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 335.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 24,245 shares of the company's stock after buying an additional 18,676 shares during the quarter. Munich Reinsurance Co Stock Corp in Munich's holdings in HCA Healthcare were worth $11,474,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Cerity Partners LLC boosted its position in shares of HCA Healthcare by 13.1% during the 3rd quarter. Cerity Partners LLC now owns 43,920 shares of the company's stock valued at $18,719,000 after acquiring an additional 5,092 shares during the last quarter. National Pension Service boosted its position in shares of HCA Healthcare by 2.9% during the 3rd quarter. National Pension Service now owns 626,585 shares of the company's stock valued at $267,051,000 after acquiring an additional 17,531 shares during the last quarter. Savant Capital LLC lifted its position in HCA Healthcare by 37.7% in the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company's stock worth $1,938,000 after buying an additional 1,246 shares during the last quarter. Sector Gamma AS lifted its position in HCA Healthcare by 36.0% in the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company's stock worth $4,638,000 after buying an additional 2,883 shares during the last quarter. Finally, Nordea Investment Management AB lifted its position in HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company's stock worth $507,393,000 after buying an additional 108,849 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Down 8.6%

Shares of HCA stock opened at $433.04 on Friday. The business's fifty day moving average is $505.45 and its 200 day moving average is $485.06. HCA Healthcare, Inc. has a twelve month low of $321.39 and a twelve month high of $556.52. The stock has a market cap of $96.81 billion, a price-to-earnings ratio of 15.26, a PEG ratio of 1.59 and a beta of 1.36.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the firm posted $6.45 earnings per share. The company's revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 30.15 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare's dividend payout ratio is presently 10.99%.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Revenue and demand beat/strength: Q1 revenue rose ~4.3% to $19.11B and the company cited strong medical care demand; some outlets note the company beat profit estimates on service demand. HCA Healthcare beats quarterly profit estimates on medical care demand
• Positive Sentiment: Margins still meaningful: HCA reported a ~12% operating margin in Q1, showing underlying profitability despite a dynamic operating environment. HCA posts 12% operating margin in Q1: 8 things to know
• Neutral Sentiment: Official results and call: HCA reported EPS of $7.15 and released its earnings call transcript and press release (revenue in line with consensus). These documents give full context on volumes, mix and expense items for analysts. HCA Healthcare Reports First Quarter 2026 Results Q1 2026 Earnings Call Transcript
• Negative Sentiment: Volume weakness weighed heavily: Surgical volumes softened and total volumes missed seasonal expectations, which traders flagged as the main reason for the share decline despite a near-term beat on profits. HCA Healthcare stock plunges nearly 8% on weak volume trends despite Q1 beat
• Negative Sentiment: EPS/guidance miss vs. street: Reported EPS was roughly flat to estimates (small miss on some models) and FY26 guidance of $29.10–$31.50 EPS (and revenue range) sits slightly below consensus, prompting downward revisions. HCA Trading/Guidance Summary
• Negative Sentiment: Policy and longer-term growth concerns: Analysts warn policy headwinds (Medicaid/ACA subsidy rollbacks) may limit admissions growth to low single digits over coming years — a reason at least one shop trimmed upside and moved to Hold. Policy Pressures May Be Limiting Admissions (Upgrade)
• Negative Sentiment: Rising expenses and margin retracement: Several reports cite higher expenses and a ~50 bps margin retracement in the quarter, which combined with volume softness amplifies near-term earnings risk. Q1 Earnings Miss on Rising Expenses

Analysts Set New Price Targets

Several brokerages have weighed in on HCA. Sanford C. Bernstein set a $541.00 price objective on HCA Healthcare in a research report on Monday, February 9th. Oppenheimer boosted their price objective on HCA Healthcare from $500.00 to $540.00 and gave the company an "outperform" rating in a research report on Wednesday, January 28th. Robert W. Baird lowered their price objective on HCA Healthcare from $450.00 to $442.00 and set a "neutral" rating for the company in a research report on Wednesday, April 15th. UBS Group boosted their price objective on HCA Healthcare from $598.00 to $635.00 and gave the company a "buy" rating in a research report on Monday, February 23rd. Finally, Royal Bank Of Canada boosted their target price on HCA Healthcare from $525.00 to $555.00 and gave the company an "outperform" rating in a research note on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $534.41.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares of the company's stock, valued at approximately $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 15,214 shares of company stock valued at $7,797,595. Company insiders own 1.50% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.